Pallini, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 8.974
AS - Asia 7.396
EU - Europa 6.612
SA - Sud America 1.609
AF - Africa 196
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 24.810
Nazione #
US - Stati Uniti d'America 8.778
SG - Singapore 3.150
CN - Cina 2.109
BR - Brasile 1.337
PL - Polonia 1.200
SE - Svezia 1.198
DE - Germania 1.158
IT - Italia 738
VN - Vietnam 686
FR - Francia 498
UA - Ucraina 457
IE - Irlanda 331
IN - India 281
GB - Regno Unito 255
ID - Indonesia 244
RU - Federazione Russa 190
FI - Finlandia 186
JP - Giappone 175
TR - Turchia 163
AR - Argentina 107
BD - Bangladesh 101
HK - Hong Kong 93
AT - Austria 87
CA - Canada 81
IQ - Iraq 73
MX - Messico 68
NL - Olanda 59
BE - Belgio 55
KR - Corea 50
ZA - Sudafrica 48
EC - Ecuador 47
PK - Pakistan 41
CH - Svizzera 37
MA - Marocco 35
RO - Romania 34
CI - Costa d'Avorio 26
ES - Italia 26
CY - Cipro 25
CO - Colombia 24
VE - Venezuela 24
KE - Kenya 21
SA - Arabia Saudita 21
UZ - Uzbekistan 20
CL - Cile 18
JO - Giordania 18
NP - Nepal 17
PY - Paraguay 17
BZ - Belize 15
PE - Perù 15
BG - Bulgaria 14
PH - Filippine 14
DZ - Algeria 13
KZ - Kazakistan 13
AE - Emirati Arabi Uniti 12
AL - Albania 11
IL - Israele 11
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
EG - Egitto 10
GR - Grecia 10
IR - Iran 10
TN - Tunisia 10
BO - Bolivia 9
LT - Lituania 9
UY - Uruguay 9
BY - Bielorussia 7
ET - Etiopia 7
MY - Malesia 7
NZ - Nuova Zelanda 7
OM - Oman 7
PT - Portogallo 7
AU - Australia 6
HU - Ungheria 6
JM - Giamaica 6
DO - Repubblica Dominicana 5
HN - Honduras 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
CM - Camerun 4
EE - Estonia 4
GE - Georgia 4
LB - Libano 4
LV - Lettonia 4
MU - Mauritius 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
AM - Armenia 3
BH - Bahrain 3
CR - Costa Rica 3
DK - Danimarca 3
KW - Kuwait 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
SN - Senegal 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 24.770
Città #
Singapore 1.625
Warsaw 1.179
Ashburn 1.041
San Jose 817
Chandler 785
Fairfield 386
Beijing 381
Hangzhou 349
Dublin 326
Ann Arbor 289
Jacksonville 267
Wilmington 260
Houston 258
Woodbridge 256
Nanjing 224
The Dalles 214
Ho Chi Minh City 208
Jakarta 208
Seattle 193
San Mateo 186
Lauterbourg 179
New York 172
Hanoi 165
Hefei 163
Tokyo 159
Los Angeles 156
Boston 141
Chicago 135
Redmond 133
Bremen 132
Cattolica 123
São Paulo 121
Izmir 118
Moscow 116
Cambridge 112
Munich 106
Nanchang 106
Princeton 103
Dearborn 102
Rome 101
Milan 96
Council Bluffs 93
Frankfurt am Main 90
Hong Kong 87
Helsinki 81
Dallas 77
Vienna 71
Lawrence 64
Hyderabad 60
Marseille 57
Redwood City 54
Brussels 52
Paris 51
Santa Clara 51
Seoul 50
Shenyang 49
London 48
Kent 43
Kunming 42
Norwalk 42
Da Nang 41
Tianjin 41
Buffalo 39
Brooklyn 38
Dong Ket 37
Rio de Janeiro 37
Shanghai 37
Zhengzhou 36
Nuremberg 34
Orem 34
Brasília 32
Haiphong 32
Hebei 32
Stockholm 32
Changsha 31
Belo Horizonte 30
Guangzhou 27
Phoenix 27
Abidjan 26
Montreal 25
Mountain View 25
Nürnberg 25
Baghdad 22
Dhaka 22
Jiaxing 22
Johannesburg 22
Mcallen 22
North Bergen 22
Pune 22
University Park 22
Chennai 20
Curitiba 20
Naples 20
Porto Alegre 20
Denver 18
Düsseldorf 18
Fortaleza 18
Goiânia 18
San Francisco 18
Amman 17
Totale 14.434
Nome #
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 503
Olfactory groove meningioma: report of 99 cases surgically treated at the Catholic University School of Medicine, Rome 411
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts 388
Deregulated expression of the imprinted DLK1-DIO3 region in Glioblastoma Stem-like Cells: tumor suppressor role of lncRNA MEG3 382
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 372
(1) H NMR detects different metabolic profiles in glioblastoma stem-like cells 343
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 343
(1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness. 326
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 299
(1)H NMR detects different metabolic profiles in glioblastoma stem-like cells 294
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 289
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway 276
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology 276
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 272
Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1 246
Gene Expression Analysis of PTEN Positive Glioblastoma Stem Cells Identifies DUB3 and Wee1 Modulation in a Cell Differentiation Model 245
Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo 243
Simultaneously occurring tumours within the same cerebello-pontine angle: refining literature definitions and proposal for classification 229
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 210
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 209
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 209
1H NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a marker of tumor aggressiveness 202
Impact of 4K Ultra-High Definition Endoscope in Pituitary Surgery: Analysis of a Comparative Institutional Case Series 196
Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist 193
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology. 186
Superior cervical ganglion regenerating axons through peripheral nerve grafts and reversal of behavioral deficits in hemiparkinsonian rats 181
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 180
Brain invasion along perivascular spaces by glioma cells: Relationship with blood–brain barrier 175
Studies on the degenerative and regenerative phenomena occurring after transection and repair of the sciatic nerve in rats: effects of acetyl-L-carnitine 170
Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra. 162
Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts. 162
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 159
Levocarnitine acetyl prevents cell death following long-term section of the vagus nerve in rats 156
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 155
Lower trunk of brachial plexus injury in the neonate rat: effects of timing reapir 153
Effects of L-carnitine, L-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats 153
The third nerve transection and regeneration in rats with preliminary results on the sixth nerve transection and regeneration in guinea pigs 148
Transferrin receptor 2 is frequently and highly expressed in glioblastomas 147
Malignant craniopharyngioma and radiotherapy: The missing link 145
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 144
Factors associated with cerebrospinal fluid leak after a retrosigmoid approach for cerebellopontine angle surgery 144
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models 142
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 139
Tumors of the peripheral nervous system: Analysis of prognostic factors in a series with long-term follow-up and review of the literature 138
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 138
Levocarnitine acetyl prevents cell death following long-term section of the vagus nerve in rats 137
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 136
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 136
First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii 136
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 135
Molecular Analysis in a Glioblastoma Cohort—Results of a Prospective Analysis 135
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 134
Experimental repair of the oculomotor nerve: the anatomical paradigms of functional regeneration 133
Oculomotor nerve regeneration in rats. Functional, histological, and neuroanatomical studies 133
The adult "paraplegic" rat: treatment with cell grafting 132
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide 131
1H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness 131
Orbital Tumors: Report of 70 Surgically Treated Cases 131
Neurosurgical Defeats: Critically Ill Patients and the Role of Palliative Care Service 129
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression 128
Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model 128
Endothelial trans-differentiation in glioblastoma recurring after radiotherapy 128
1H NMR detects different metabolic profiles in glioblastoma stem-like cells 126
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 126
Studies on embryonic transplants to the transected spinal cord of adult rats 125
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo. 125
FMRP modulates the Wnt signalling pathway in glioblastoma 124
5-Aminolevulinic Acid (5-ALA)–Induced Protoporphyrin IX Fluorescence by Glioma Cells. A Fluorescence Microscopy Clinical Study 124
Communicating hydrocephalus following surgery and adjuvant radiochemotherapy for glioblastoma 124
Callosotomy for generalized seizures associated with hypothalamic hamartoma 124
Teaching NeuroImages: extralesional bleeding of conus medullaris cavernoma. 124
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 124
Spinal cord transection in adult rats: effects of local infusion of nerve growth factor on the corticospinal tract axons 123
Hydrocephalus and macrocrania: surgical or non-surgical treatment of postshunting subdural hematoma? 123
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells 123
Comparison of combined anterior–posterior and posterior-only approaches for lumbosacral chordomas: a systematic review and meta-analysis of surgical and clinical outcomes 123
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2 121
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma 121
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 119
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 119
Telomerase inhibition in malignant gliomas. A systematic review 118
De novo malignant craniopharyngioma: case report and literature review. 118
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 117
Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro study 117
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome 116
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells 116
Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. 115
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 113
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach 113
Prognostic impact of MGMT promoter methylation in glioblastoma - a systematic review 111
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme 111
Personalized Medicine in Brain Tumors 110
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis 110
Glioblastoma of the optic chiasm 109
Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature 108
Dilation of Brain Veins and Perivascular Infiltration by Glioblastoma Cells in an in Vivo Assay of Early Tumor Angiogenesis 108
Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration 107
Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature Review 106
Mir-370-3p impairs glioblastoma stem-like cell malignancy regulating a complex interplay between HMGA2/HIF1A and the oncogenic long non-coding RNA (LncRNA) neat1 106
Resection versus biopsy for management of primary central nervous system lymphoma: a meta-analysis 103
Totale 16.936
Categoria #
all - tutte 98.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021398 0 0 0 0 0 0 0 0 0 178 159 61
2021/20221.528 181 174 74 98 106 67 38 171 96 80 208 235
2022/20232.808 404 346 243 412 237 295 130 217 308 77 84 55
2023/20241.583 61 452 46 169 59 155 109 51 22 72 183 204
2024/20253.306 100 69 279 142 200 116 93 136 544 352 726 549
2025/20268.588 1.353 340 661 1.139 1.494 462 1.600 426 595 518 0 0
Totale 25.146